Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

High Point Pharmaceuticals Llc
High Point Pharmaceuticals Llc_20100114
  

High Point Pharmaceuticals Llc patents

Recent patent applications related to High Point Pharmaceuticals Llc. High Point Pharmaceuticals Llc is listed as an Agent/Assignee. Note: High Point Pharmaceuticals Llc may have other listings under different names/spellings. We're not affiliated with High Point Pharmaceuticals Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "H" | High Point Pharmaceuticals Llc-related inventors




Date High Point Pharmaceuticals Llc patents (updated weekly) - BOOKMARK this page
03/12/15Use of a ppar-delta agonist for treating muscle atrophy
12/18/14Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors
07/17/14Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
03/06/14Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
01/23/14Phenoxy acetic acids and phenyl propionic acids as ppar delta agonists
09/26/13Compounds that modulate oxidative stress
09/05/13N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
04/25/13Phenoxy acetic acids as ppar delta activators
09/13/12Novel medicaments
09/13/12Phenoxy acetic acids as ppar delta activators
07/05/12Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors
04/26/12Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
04/26/12Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
03/22/12Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
02/23/12Novel compounds, their preparation and use
02/02/12Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
01/12/1211-beta-hydroxysteroid dehydrogenase type 1 active compounds
01/05/1211-beta-hydroxysteroid dehydrogenase type 1 active compounds
12/22/11Pharmaceutical use of substituted amides
10/06/11Phenoxy acetic acids as ppar delta activators
09/29/11Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
09/15/11Adamantyl benzamide derivatives
08/18/11Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
07/28/11Phenoxy acetic acids as ppar delta activators
06/30/11Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
06/30/11Tricyclic compounds as modulators of tnf-alpha synthesis and as pde4 inhibitors
03/24/116- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
03/17/11Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
02/17/11N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
01/13/11Histamine h3 receptor ligands
11/25/10Benzothiazoles having histamine h3 receptor activity
11/18/1011beta-hydroxysteroid dehydrogenase type 1 active compounds
10/21/10Heterocyclic h3 antagonists
08/19/10Novel compounds, their preparations and use
08/05/10Pharmaceutical use of fused 1,2,4-triazoles
07/29/10Tricyclic compounds as modulators of tnf-alpha synthesis
05/13/1011beta-hydroxysteroid dehydrogenase type 1 active compounds
03/25/10Novel salicylic anilides
01/14/1011beta-hydroxysteroid dehydrogenase type 1 active compounds
12/17/09Novel medicaments
10/22/09Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
10/22/09Amide derivatives and pharmaceutical use thereof
10/22/09Novel aryl- and heteroarylpiperazines
07/09/093-(l,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-l-yl)-pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
02/19/09Compounds that modulate ppar activity, their preparation and use
01/14/1011beta-hydroxysteroid dehydrogenase type 1 active compounds







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with High Point Pharmaceuticals Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for High Point Pharmaceuticals Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';